Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02146833
Title Study of Selinexor (KPT-330) in Metastatic Castrate Resistant Prostate Adenocarcinoma
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Karyopharm Therapeutics, Inc
Indications

prostate adenocarcinoma

Therapies

Selinexor

Age Groups: adult
Covered Countries USA


No variant requirements are available.